Global Medical Inhaler Market Research Report 2021

1 Medical Inhaler Market Overview

• 1.1 Product Overview and Scope of Medical Inhaler
• 1.2 Medical Inhaler Segment by Type
  • 1.2.1 Global Medical Inhaler Sales Growth Rate Comparison by Type (2021-2027)
  • 1.2.2 Pressurised Metered Dose Inhaler (PMDI)
  • 1.2.3 Dry Powder Inhaler (DPI)
  • 1.2.4 Others
• 1.3 Medical Inhaler Segment by Application
  • 1.3.1 Medical Inhaler Sales Comparison by Application: (2021-2027)
  • 1.3.2 Asthma
  • 1.3.3 Chronic Obstructive Pulmonary Disease (COPD)
  • 1.3.4 Allergic Rhinitis
• 1.4 Global Medical Inhaler Market Size Estimates and Forecasts
  • 1.4.1 Global Medical Inhaler Revenue 2016-2027
  • 1.4.2 Global Medical Inhaler Sales 2016-2027
  • 1.4.3 Medical Inhaler Market Size by Region: 2016 Versus 2021 Versus 2027

2 Medical Inhaler Market Competition by Manufacturers

• 2.1 Global Medical Inhaler Sales Market Share by Manufacturers (2016-2021)
• 2.2 Global Medical Inhaler Revenue Market Share by Manufacturers (2016-2021)
• 2.3 Global Medical Inhaler Average Price by Manufacturers (2016-2021)
• 2.4 Manufacturers Medical Inhaler Manufacturing Sites, Area Served, Product Type
• 2.5 Medical Inhaler Market Competitive Situation and Trends
  • 2.5.1 Medical Inhaler Market Concentration Rate
  • 2.5.2 The Global Top 5 and Top 10 Largest Medical Inhaler Players Market Share by Revenue
  • 2.5.3 Global Medical Inhaler Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
• 2.6 Manufacturers Mergers & Acquisitions, Expansion Plans

3 Medical Inhaler Retrospective Market Scenario by Region

• 3.1 Global Medical Inhaler Retrospective Market Scenario in Revenue by Region: 2016-2021
• 3.2 Global Medical Inhaler Retrospective Market Scenario in Sales by Region: 2016-2021
• 3.3 North America Medical Inhaler Market Facts & Figures by Country
  • 3.3.1 North America Medical Inhaler Sales by Country
  • 3.3.2 North America Medical Inhaler Revenue by Country
  • 3.3.3 U.S.
  • 3.3.4 Canada
• 3.4 Europe Medical Inhaler Market Facts & Figures by Country
  • 3.4.1 Europe Medical Inhaler Sales by Country
  • 3.4.2 Europe Medical Inhaler Revenue by Country
  • 3.4.3 Germany
  • 3.4.4 France
  • 3.4.5 U.K.
  • 3.4.6 Italy
  • 3.4.7 Russia
• 3.5 Asia Pacific Medical Inhaler Market Facts & Figures by Region
  • 3.5.1 Asia Pacific Medical Inhaler Sales by Region
  • 3.5.2 Asia Pacific Medical Inhaler Revenue by Region
  • 3.5.3 China
  • 3.5.4 Japan
  • 3.5.5 South Korea
  • 3.5.6 India
  • 3.5.7 Australia
  • 3.5.8 Taiwan
  • 3.5.9 Indonesia
  • 3.5.10 Thailand
  • 3.5.11 Malaysia
  • 3.5.12 Philippines
  • 3.5.13 Vietnam
• 3.6 Latin America Medical Inhaler Market Facts & Figures by Country
  • 3.6.1 Latin America Medical Inhaler Sales by Country
  • 3.6.2 Latin America Medical Inhaler Revenue by Country
  • 3.6.3 Mexico
  • 3.6.4 Brazil
  • 3.6.5 Argentina
• 3.7 Middle East and Africa Medical Inhaler Market Facts & Figures by Country
  • 3.7.1 Middle East and Africa Medical Inhaler Sales by Country
  • 3.7.2 Middle East and Africa Medical Inhaler Revenue by Country
  • 3.7.3 Turkey
  • 3.7.4 Saudi Arabia
  • 3.7.5 UAE

4 Global Medical Inhaler Historic Market Analysis by Type

• 4.1 Global Medical Inhaler Sales Market Share by Type (2016-2021)
• 4.2 Global Medical Inhaler Revenue Market Share by Type (2016-2021)
• 4.3 Global Medical Inhaler Price by Type (2016-2021)

5 Global Medical Inhaler Historic Market Analysis by Application

• 5.1 Global Medical Inhaler Sales Market Share by Application (2016-2021)
• 5.2 Global Medical Inhaler Revenue Market Share by Application (2016-2021)
• 5.3 Global Medical Inhaler Price by Application (2016-2021)

6 Key Companies Profiled

• 6.1 GSK
  • 6.1.1 GSK Corporation Information
  • 6.1.2 GSK Description and Business Overview
  • 6.1.3 GSK Medical Inhaler Sales, Revenue and Gross Margin (2016-2021)
  • 6.1.4 GSK Product Portfolio
  • 6.1.5 GSK Recent Developments/Updates
• 6.2 AstraZeneca
  • 6.2.1 AstraZeneca Corporation Information
  • 6.2.2 AstraZeneca Description and Business Overview
  • 6.2.3 AstraZeneca Medical Inhaler Sales, Revenue and Gross Margin (2016-2021)
  • 6.2.4 AstraZeneca Product Portfolio
  • 6.2.5 AstraZeneca Recent Developments/Updates
• 6.3 Boehringer Ingelheim
  • 6.3.1 Boehringer Ingelheim Corporation Information
  • 6.3.2 Boehringer Ingelheim Description and Business Overview
  • 6.3.3 Boehringer Ingelheim Medical Inhaler Sales, Revenue and Gross Margin (2016-2021)
  • 6.3.4 Boehringer Ingelheim Product Portfolio
  • 6.3.5 Boehringer Ingelheim Recent Developments/Updates
• 6.4 Chiesi
  • 6.4.1 Chiesi Corporation Information
  • 6.4.2 Chiesi Description and Business Overview
  • 6.4.3 Chiesi Medical Inhaler Sales, Revenue and Gross Margin (2016-2021)
  • 6.4.4 Chiesi Product Portfolio
  • 6.4.5 Chiesi Recent Developments/Updates
• 6.5 Cipla
  • 6.5.1 Cipla Corporation Information
  • 6.5.2 Cipla Description and Business Overview
  • 6.5.3 Cipla Medical Inhaler Sales, Revenue and Gross Margin (2016-2021)
  • 6.5.4 Cipla Product Portfolio
  • 6.5.5 Cipla Recent Developments/Updates
• 6.6 3M
  • 6.6.1 3M Corporation Information
  • 6.6.2 3M Description and Business Overview
  • 6.6.3 3M Medical Inhaler Sales, Revenue and Gross Margin (2016-2021)
  • 6.6.4 3M Product Portfolio
  • 6.6.5 3M Recent Developments/Updates
• 6.7 Hovione
  • 6.6.1 Hovione Corporation Information
  • 6.6.2 Hovione Description and Business Overview
  • 6.6.3 Hovione Medical Inhaler Sales, Revenue and Gross Margin (2016-2021)
  • 6.4.4 Hovione Product Portfolio
  • 6.7.5 Hovione Recent Developments/Updates
• 6.8 Mannkind
  • 6.8.1 Mannkind Corporation Information
  • 6.8.2 Mannkind Description and Business Overview
  • 6.8.3 Mannkind Medical Inhaler Sales, Revenue and Gross Margin (2016-2021)
  • 6.8.4 Mannkind Product Portfolio
  • 6.8.5 Mannkind Recent Developments/Updates
• 6.9 Mylan
  • 6.9.1 Mylan Corporation Information
  • 6.9.2 Mylan Description and Business Overview
  • 6.9.3 Mylan Medical Inhaler Sales, Revenue and Gross Margin (2016-2021)
  • 6.9.4 Mylan Product Portfolio
  • 6.9.5 Mylan Recent Developments/Updates
• 6.10 Novartis
  • 6.10.1 Novartis Corporation Information
  • 6.10.2 Novartis Description and Business Overview
  • 6.10.3 Novartis Medical Inhaler Sales, Revenue and Gross Margin (2016-2021)
  • 6.10.4 Novartis Product Portfolio
  • 6.10.5 Novartis Recent Developments/Updates
• 6.11 Teva
  • 6.11.1 Teva Corporation Information
  • 6.11.2 Teva Medical Inhaler Description and Business Overview
  • 6.11.3 Teva Medical Inhaler Sales, Revenue and Gross Margin (2016-2021)
  • 6.11.4 Teva Product Portfolio
  • 6.11.5 Teva Recent Developments/Updates
• 6.12 Vectura
  • 6.12.1 Vectura Corporation Information
  • 6.12.2 Vectura Medical Inhaler Description and Business Overview
  • 6.12.3 Vectura Medical Inhaler Sales, Revenue and Gross Margin (2016-2021)
  • 6.12.4 Vectura Product Portfolio
  • 6.12.5 Vectura Recent Developments/Updates
• 6.13 Adherium
  • 6.13.1 Adherium Corporation Information
  • 6.13.2 Adherium Medical Inhaler Description and Business Overview
  • 6.13.3 Adherium Medical Inhaler Sales, Revenue and Gross Margin (2016-2021)
  • 6.13.4 Adherium Product Portfolio
  • 6.13.5 Adherium Recent Developments/Updates
• 6.14 Cohero Health
  • 6.14.1 Cohero Health Corporation Information
  • 6.14.2 Cohero Health Medical Inhaler Description and Business Overview
  • 6.14.3 Cohero Health Medical Inhaler Sales, Revenue and Gross Margin (2016-2021)
  • 6.14.4 Cohero Health Product Portfolio
  • 6.14.5 Cohero Health Recent Developments/Updates
• 6.15 Opko
  • 6.15.1 Opko Corporation Information
  • 6.15.2 Opko Medical Inhaler Description and Business Overview
  • 6.15.3 Opko Medical Inhaler Sales, Revenue and Gross Margin (2016-2021)
  • 6.15.4 Opko Product Portfolio
  • 6.15.5 Opko Recent Developments/Updates
• 6.16 ResMed
  • 6.16.1 ResMed Corporation Information
  • 6.16.2 ResMed Medical Inhaler Description and Business Overview
  • 6.16.3 ResMed Medical Inhaler Sales, Revenue and Gross Margin (2016-2021)
  • 6.16.4 ResMed Product Portfolio
  • 6.16.5 ResMed Recent Developments/Updates
• 6.17 Beximco Pharma
  • 6.17.1 Beximco Pharma Corporation Information
  • 6.17.2 Beximco Pharma Medical Inhaler Description and Business Overview
  • 6.17.3 Beximco Pharma Medical Inhaler Sales, Revenue and Gross Margin (2016-2021)
  • 6.17.4 Beximco Pharma Product Portfolio
  • 6.17.5 Beximco Pharma Recent Developments/Updates

7 Medical Inhaler Manufacturing Cost Analysis

• 7.1 Medical Inhaler Key Raw Materials Analysis
  • 7.1.1 Key Raw Materials
  • 7.1.2 Key Suppliers of Raw Materials
• 7.2 Proportion of Manufacturing Cost Structure
• 7.3 Manufacturing Process Analysis of Medical Inhaler
• 7.4 Medical Inhaler Industrial Chain Analysis

8 Marketing Channel, Distributors and Customers

• 8.1 Marketing Channel
• 8.2 Medical Inhaler Distributors List
• 8.3 Medical Inhaler Customers

9 Medical Inhaler Market Dynamics

• 9.1 Medical Inhaler Industry Trends
• 9.2 Medical Inhaler Growth Drivers
• 9.3 Medical Inhaler Market Challenges
• 9.4 Medical Inhaler Market Restraints

10 Global Market Forecast

• 10.1 Medical Inhaler Market Estimates and Projections by Type
  • 10.1.1 Global Forecasted Sales of Medical Inhaler by Type (2022-2027)
  • 10.1.2 Global Forecasted Revenue of Medical Inhaler by Type (2022-2027)
• 10.2 Medical Inhaler Market Estimates and Projections by Application
  • 10.2.1 Global Forecasted Sales of Medical Inhaler by Application (2022-2027)
  • 10.2.2 Global Forecasted Revenue of Medical Inhaler by Application (2022-2027)
• 10.3 Medical Inhaler Market Estimates and Projections by Region
  • 10.3.1 Global Forecasted Sales of Medical Inhaler by Region (2022-2027)
  • 10.3.2 Global Forecasted Revenue of Medical Inhaler by Region (2022-2027)

11 Research Finding and Conclusion

12 Methodology and Data Source

• 12.1 Methodology/Research Approach
  • 12.1.1 Research Programs/Design
  • 12.1.2 Market Size Estimation
  • 12.1.3 Market Breakdown and Data Triangulation
• 12.2 Data Source
  • 12.2.1 Secondary Sources
  • 12.2.2 Primary Sources
• 12.3 Author List